Skip to main content
Back to companies
South San Francisco, California, United StatesFounded 202141+ employeesPrivate
$78M raisedSeries A· last: series a (Nov 2022)· 1 rounds
Backed by(9 investors)

Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it. Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.

Founders

Skip jobs list

Open Positions at Rezo Therapeutics (4 Jobs)

4 open

Showing 4 jobs